Herce, Michael E.
Cassidy, Caitlin
Munson, Alexandra
Edwards, Jessie K.
Rutstein, Sarah E.
Matoga, Mitch
Kumwenda, Chimwemwe
Simon, Katherine R.
van Oosterhout, Joep J.
Cox, Carrie M.
Kamanga, Funny
Kumwenda, Wiza
Phiri, Sam
Rambiki, Ethel
Thawani, Agness
Huwa, Jacqueline
Malewezi, Bridget
Mvalo, Tisu
Bula, Agatha
Chinula, Lameck
Hoffman, Irving
Squibb, Madeleine A.
Nyirenda, Rose K.
Saidi, Friday
Hosseinipour, Mina C.
Chagomerana, Maganizo B.
Funding for this research was provided by:
National Institute of Child Health and Human Development (P01HD112215)
Article History
Received: 8 February 2025
Accepted: 6 July 2025
First Online: 28 July 2025
Declarations
:
: The trial protocol (version 1.0, date 12 March, 2024) was approved by the University of North Carolina Institutional Review Board (#24–0561) and the Malawi National Health Science Research Committee (#24/02/4365). All study participants must provide written informed consent to participate in the trial. Any amendment(s) to the protocol will require review and approval by all regulatory authorities before the changes can be implemented in the study and will be documented in ClinicalTrials.gov.
: Not applicable.
: The authors declare that they have no competing interests.